Paul W. Hoelscher, EVP, CFO at Horizon Therapeutics Public Ltd Co (HZNP), sold 614,090 shares at $110.01 ($67.6M) on 2022-04-06, disclosed to the SEC on 2022-04-08.
Open-market sale of $67.6M HZNP by EVP, CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $110.01 | 91,710 | $10.1M | 14.9% |
| 2 | $110.01 | 91,710 | $10.1M | 14.9% |
| 3 | $110.01 | 215,335 | $23.7M | 35.1% |
| 4 | $110.01 | 215,335 | $23.7M | 35.1% |
| Total | $110.01 avg | 614,090 | $67.6M | 100% |
| Filing → |
| HZNP | SELL | 2021-12-30 | $943K | — | Filing → |
| HZNP | SELL | 2021-05-14 | $18.5M | — | Filing → |
| HZNP | SELL | 2020-08-25 | $4.5M | — | Filing → |